TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth.
Ontology highlight
ABSTRACT: Despite advances in treatment for metastatic melanoma patients, patients with liver metastasis have an unfavorable prognosis. A better understanding of the development of liver metastasis is needed. The multifunctional cytokine Transforming Growth Factor β (TGF-β) plays various roles in melanoma tumors and metastasis, affecting both tumor cells and cells from the surrounding tumor microenvironment. To study the role of TGF-β in melanoma liver metastasis, we created a model to activate or repress the TGF-β receptor pathway in vitro and in vivo in an inducible manner. For this, we engineered B16F10 melanoma cells to have inducible ectopic expression of a constitutively active (ca) or kinase-inactive (ki) TGF-β receptor I, also termed activin receptor-like kinase (ALK5). In vitro, stimulation
SUBMITTER: Marvin DL
PROVIDER: S-EPMC10218053 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA